SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as investors debate the impact of a massive share authorization and potential acquisition strategies involving eBay, while community sentiment remains sharply divided between those bracing for further dilution and those anticipating a major short squeeze. The conversation is further fueled by high-stakes speculation surrounding upcoming shareholder meetings and lingering frustration over the lack of concrete strategic guidance from leadership.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is currently trending following a major 20-year lease agreement with Anthropic valued at approximately $19 billion, a deal that investors view as a pivotal validation of the company's strategic pivot toward AI infrastructure. While the community is actively debating the potential for a short squeeze and long-term valuation growth, sentiment remains divided between bulls focused on the company's execution and bears concerned about recent price volatility and management's timing.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is experiencing high volatility as investors weigh a recent beat on delivery estimates and raised full-year production guidance against a fresh, dilutive public offering of 75 million shares. While some community members view the capital raise as a strategic move to secure DOE loan funding for facility expansion, many investors are expressing frustration over the dilution, leading to a sharp, polarized debate between those focusing on long-term growth and those fearing further downward pressure on the stock.

Penguin Solutions, Inc. engages in designing, building, and managing enterprise solutions. It operates through the following segments: Advanced Computing, Integrated Memory, and Optimized LED. The Advanced Computing segment offers platform solutions and services for artificial intelligence, high-performance computing, machine learning, advanced modeling, and the internet of things. The Integrated Memory refers to integrated memory solutions through the design and development. The Optimized LED segment comprises a broad portfolio of application-optimized LEDs. The company was founded in 1988 and is headquartered in Fremont, CA.

Penguin Solutions Inc.

Penguin Solutions is trending as investors digest a surge in AI-driven revenue and its growing role as a specialized infrastructure partner within the NVIDIA ecosystem. Community discourse is heavily divided between those highlighting its potential as an undervalued infrastructure play with strong institutional backing and others concerned about price volatility and potential dilution heading into earnings.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is facing extreme volatility as investors rotate out of semiconductor stocks, fueled by uncertainty over whether the AI growth narrative is experiencing a temporary correction or a deeper repricing. Community sentiment is deeply divided, with many traders aggressively buying the dip in hopes of a swift V-shaped recovery while others warn of a structural bubble bursting and significant decay risks in leveraged ETFs.

Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the development of imdusiran (AB-729), proprietary, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic, and AB-101, proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV). The company was founded on October 6, 2005 and is headquartered in Warminster, PA.

Arbutus Biopharma Corp

Arbutus Biopharma is trending as investors digest the recent FDA Fast Track designation for its lead hepatitis B candidate, while community members remain hyper-focused on the potential for massive settlements with big pharmaceutical companies and a long-awaited breakout above a stagnant trading range. The discourse is dominated by frustration over alleged market manipulation and management's perceived lack of transparency, balanced against high expectations for institutional accumulation and a potential multi-billion dollar windfall from ongoing patent litigation.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is trending as investors react to a strategic manufacturing alliance with Toyota, which aims to scale production for its S4 series electric air taxi. The community remains heavily divided between long-term bulls highlighting FAA certification progress and partnerships, and vocal short-sellers betting against cash burn and potential dilution.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

Compass Pathways is trending as market anticipation builds for the release of Phase 3 durability data, which is widely considered the final hurdle before the company's New Drug Application submission. The community is heavily focused on the stock's potential as a first-mover in the treatment-resistant depression space, with bullish sentiment bolstered by recent board expansions and ongoing federal interest in accelerating psychedelic therapy approvals.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is trending as investors speculate on a potential buyout, fueled by the company's strong commercial growth, label expansion efforts into indications like myasthenia gravis and schizophrenia, and expectations for the upcoming subcutaneous Briumvi rollout. The community is actively discussing bullish price action, recent institutional accumulation, and the belief that the stock remains undervalued compared to peers, keeping M&A sentiment high.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is gaining momentum as investors anticipate upcoming maintenance trial data, fueling speculation about a potential buyout or major partnership with pharmaceutical giants. Community discussions are centered on the stock's long-term value relative to sector leaders, with many bulls actively bracing for a potential short squeeze as institutional accumulation continues.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

@BioRich 

FTI
Tuesday, 07/07/2026 9:08:05 AM
Another positive milestone for $BCTX as BriaCell expands commercial-readiness efforts for Bria-IMT, its Phase 3 metastatic breast cancer immunotherapy candidate.

Mark

Tim H

StockTwits for iOS

BriaCell Therapeutics Corp

 

FTI
Tuesday, 07/07/2026 9:08:05 AM
Another positive milestone for 

 as BriaCell expands commercial-readiness efforts for Bria-IMT, its Phase 3 metastatic breast cancer immunotherapy candidate.